Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-25 @ 10:33 PM
Study NCT ID:
NCT03253068
Status:
UNKNOWN
Last Update Posted:
2020-05-19
First Post:
2017-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
Sponsor:
Wakayama Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MK-3475-IIT-55441
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |